How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China
Value in Health · 2026-08
DOI: 10.1016/j.jval.2026.07.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-08. Verfasst von Chenglong Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: China's National Volume-Based Procurement (NVBP) program centrally tenders selected off-patent molecules. Winning products are purchased under contracted volumes at discounted prices, whereas nonwinning products may remain available outside the contracted volume. We assessed how NVBP tender waves 2 to 5 affected procurement prices and first-year public procurement spending. METHODS: We used monthly hospital procurement records from 29 mainland provincial-level regions during 2019 to 2022, measured at the product-province-month level, for 5 therapeutic areas. Prices were measured as defined daily cost in Chinese yuan. We estimated log-price effects using dynamic difference-in-differences models for staggered treatment timing across molecules. We then mapped estimated price changes onto one-year public procurement spending under fixed-share and realized-reallocation scenarios. RESULTS: Defined daily cost fell by 58% for winning products and by 10% for nonwinning products. Baseline spending was CNY 2.82 trillion. Estimated savings were CNY 779.9 billion (27.7%) under the fixed-share scenario and CNY 1038.1 billion (36.9%) under the realized-reallocation scenario. CONCLUSIONS: NVBP was associated with large direct price reductions and smaller spillover reductions, yielding substantial procurement savings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Electronic address: mingyue0204@xjtu.edu.cn.
Zitieren
APA
Lin, C., Zhao, M., Saeed, A., & Fang, Y. (2026). How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China. Value in Health. https://doi.org/10.1016/j.jval.2026.07.013
Vancouver
Lin C, Zhao M, Saeed A, Fang Y. How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China. Value in Health. 2026. doi:10.1016/j.jval.2026.07.013
BibTeX
@article{Lin2026,
author = {Lin, Chenglong and Zhao, Mingyue and Saeed, Amna and Fang, Yu},
title = {How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China},
journal = {Value in Health},
year = {2026},
doi = {10.1016/j.jval.2026.07.013}
}
EUVIMED